Immunotherapy for metastatic colorectal cancer: Present status and new options. Jan 2012 - :1502-7708 [PMID:22214467] [Ellebaek E] [Andersen MH] [Svane IM] [Straten PT]
Effector CD8(+ )T cell IFN-γ production and cytotoxicity are enhanced by mild hyperthermia. Jan 2012 - Int J Hyperthermia; 28(1):1464-5157 [PMID:22235780] [Mace TA] [Zhong L] [Kokolus KM] [Repasky EA]
Newcastle Disease Virus LaSota Strain Kills Human Pancreatic Cancer Cells in Vitro with High Selectivity. Jan 2012 - JOP; 13(1):1590-8577 [PMID:22233946] [Walter RJ] [Attar BM] [Rafiq A] [Tejaswi S] [Delimata M]
Inhibition of checkpoint kinase 1 abrogates G2/M checkpoint activation and promotes apoptosis under heat stress. Jan 2012 - Apoptosis; 17(1):1573-675X [PMID:22080164] [Furusawa Y] [Iizumi T] [Fujiwara Y] [Zhao QL] [Tabuchi Y] [Nomura T] [Kondo T]
Newcastle Disease Virus: a Promising Agent for Tumor Immunotherapy. Jan 2012 - :1440-1681 [PMID:22211810] [Zhao L] [Liu H]
Hyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human colon cancer cells. Dec 2011 - :1097-4644 [PMID:22174016] [Song X] [Kim HC] [Kim SY] [Basse P] [Park BH] [Lee BC] [Lee YJ]
Immunotherapy of Lung Adenocarcinoma Patient with Peptide-Pulsed Dendritic Cells: a Case Report. Dec 2011 - :1661-4917 [PMID:22143160] [Wojas-Krawczyk K] [Krawczyk P] [Buczkowski J] [Walkowska A] [Jankowska O] [Czekajska-Chehab E] [Milanowski J]
Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo. Dec 2011 - :1873-5835 [PMID:22133641] [Alabsi AM] [Ali R] [Ideris A] [Omar AR] [Bejo MH] [Yusoff K] [Ali AM]
Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo. Dec 2011 - :1872-7980 [PMID:22095029] [Meng S] [Zhou Z] [Chen F] [Kong X] [Liu H] [Jiang K] [Liu W] [Hu M] [Zhang X] [Ding C] [Wu Y]
Safety and clinical usage of newcastle disease virus in cancer therapy. Dec 2011 - J. Biomed. Biotechnol.; 2011:1110-7251 [PMID:22131816] [Lam HY] [Yeap SK] [Rasoli M] [Omar AR] [Yusoff K] [Suraini AA] [Banu Alitheen N]
A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast Cancer. Dec 2011 - :1537-4513 [PMID:22130160] [Koski GK] [Koldovsky U] [Xu S] [Mick R] [Sharma A] [Fitzpatrick E] [Weinstein S] [Nisenbaum H] [Levine BL] [Fox K] [Zhang P] [Czerniecki BJ]
Development of sipuleucel-T: Autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer. Nov 2011 - :1873-2518 [PMID:22122856] [Sims RB]
Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432. Nov 2011 - Int. Immunopharmacol.; 11(12):1878-1705 [PMID:22015603] [Ge C] [Xing Y] [Wang Q] [Xiao W] [Lu Y] [Hu X] [Gao Z] [Xu M] [Ma Y] [Cao R] [Liu J]
Long-term Vaccine Therapy with Autologous Whole Tumor Cell-pulsed Dendritic Cells for a Patient with Recurrent Rectal Carcinoma. Nov 2011 - Anticancer Res.; 31(11):1791-7530 [PMID:22110233] [Onishi H] [Morisaki T] [Baba E] [Nakamura M] [Inaba S] [Kuroki H] [Matsumoto K] [Katano M]
Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy. Nov 2011 - Anticancer Res.; 31(11):1791-7530 [PMID:22110227] [Tsutsumi S] [Tabe Y] [Fujii T] [Yamaguchi S] [Suto T] [Yajima R] [Morita H] [Kato T] [Shioya M] [Saito J] [Asao T] [Nakano T] [Kuwano H]
